OSE Pharma SA (OSE) — Cash Flow-to-Debt Ratio
OSE Pharma SA (OSE) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay 0% of its total liabilities (€53.58 Million) in one year. Explore OSE Pharma SA long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OSE Pharma SA Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for OSE Pharma SA across 13 annual periods. Also explore OSE Pharma SA assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for OSE Pharma SA (2012–2024)
Year-by-year debt coverage analysis for OSE Pharma SA. For market capitalisation and broader financial context, see market cap of OSE Pharma SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.81x | €48.44 Million | €60.15 Million | ▲ +340.7% |
| 2023 | -0.33x | €-19.76 Million | €59.08 Million | ▼ -8.4% |
| 2022 | -0.31x | €-18.25 Million | €59.12 Million | ▼ -68.0% |
| 2021 | -0.18x | €-9.92 Million | €53.99 Million | ▲ +66.5% |
| 2020 | -0.55x | €-19.55 Million | €35.61 Million | ▼ -286.0% |
| 2019 | 0.30x | €8.97 Million | €30.40 Million | ▲ +315.1% |
| 2018 | 0.07x | €1.08 Million | €15.15 Million | ▲ +119.5% |
| 2017 | -0.36x | €-8.00 Million | €21.91 Million | ▼ -1435.2% |
| 2016 | 0.03x | €684.00K | €25.02 Million | ▲ +101.5% |
| 2015 | -1.83x | €-4.61 Million | €2.52 Million | ▼ -163.2% |
| 2014 | -0.70x | €-1.94 Million | €2.78 Million | ▼ -253.9% |
| 2013 | -0.20x | €-236.00K | €1.20 Million | ▲ +87.1% |
| 2012 | -1.52x | €-1.39 Million | €915.00K | — |